ESCAPE Bio Funding: $184M Raised, Series C (2020)

ESCAPE Bio funding overview

ESCAPE Bio is based in South San Francisco, California. ESCAPE Bio has raised $184M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in September 2020. The round record for ESCAPE Bio runs through 2020; nothing later has been disclosed. Investors on record include Wellington Management, Avidity Partners, CAM Capital, New Leaf Ventures, Rock Springs Capital, Surveyor Capital and 8 others. 14 distinct backers are named across the disclosed rounds.

ESCAPE Bio at a glance

Total raised: $184M
Latest round: Series C
Latest round date: September 2020
Headquarters: South San Francisco, California
Notable investors: Wellington Management, Avidity Partners, CAM Capital, New Leaf Ventures, Rock Springs Capital, Surveyor Capital, Sphera Funds Management, OrbiMed

Frequently asked about ESCAPE Bio funding

How much has ESCAPE Bio raised?: ESCAPE Bio has raised $184M in total disclosed funding across the rounds on record.
Who has invested in ESCAPE Bio?: Wellington Management, Avidity Partners, CAM Capital, New Leaf Ventures, Rock Springs Capital, Surveyor Capital are named among the investors backing ESCAPE Bio.
What was the latest ESCAPE Bio funding round?: The most recent disclosed round is a Series C, announced in September 2020.
Where is ESCAPE Bio based?: ESCAPE Bio is based in South San Francisco, California.
When did ESCAPE Bio last raise?: The last disclosed ESCAPE Bio round closed in September 2020 at Series C.

ESCAPE Bio totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in South San Francisco below to benchmark round size and investor mix.

ESCAPE Bio Funding: $184M Raised, Series C (2020)

ESCAPE Bio funding overview

ESCAPE Bio at a glance

Frequently asked about ESCAPE Bio funding

Companies related to ESCAPE Bio (36)

Browse related funding lists (7)